Bravecto for Dogs: Uses, Cost & Side Effects

This information is for educational purposes only and does not replace care from your vet. Bravecto is a prescription medication, so the right product, dose, and schedule depend on your dog’s age, weight, health history, parasite risk, and any other medications they take.

See your vet immediately if your dog has trouble breathing, collapses, has repeated vomiting, severe weakness, facial swelling, or any neurologic signs such as tremors, stumbling, or seizures after a dose. If your dog has a history of seizures, breeding plans, or is pregnant or nursing, bring that up before starting any isoxazoline medication.

Bravecto does not prevent heartworm disease or intestinal parasites. Many dogs need a separate parasite plan, and your vet can help you choose an option that fits your dog’s lifestyle and your household budget.

Bravecto is a prescription flea and tick preventive for dogs that contains fluralaner, an isoxazoline medication. It works systemically, which means the drug is absorbed into your dog’s body after dosing. Fleas and ticks must bite to be exposed, so Bravecto does not repel parasites before they attach. Instead, it kills them after they feed.

For dogs, Bravecto is available as a long-acting chew that protects against fleas and several tick species for up to 12 weeks, plus a Bravecto 1-Month chew for monthly dosing. There is also a topical solution for dogs in some markets and practice settings. The 12-week chew appeals to many pet parents because it reduces how often they need to remember a dose.

That said, fewer doses is not always the best fit for every dog. Some families prefer monthly routines, some dogs do better with one formulation over another, and some regions have heavier tick pressure. Your vet can help match the product to your dog’s risk level, medical history, and your ability to stay on schedule.

Bravecto is FDA-approved in dogs for the treatment and prevention of flea infestations and for the treatment and control of several tick species. The labeled tick coverage includes black-legged ticks, American dog ticks, brown dog ticks, and Asian longhorned ticks for up to 12 weeks. For lone star ticks, labeled control is shorter, at 8 weeks, which matters in parts of the United States where lone star ticks are common.

Bravecto starts killing fleas quickly, and product materials describe activity beginning within hours. That fast kill can help reduce flea bites and may support control of flea allergy dermatitis when used as part of a broader skin plan.

Vets may also use fluralaner off-label for mite problems such as demodectic mange or sarcoptic mange. Off-label use is common in veterinary medicine, but it should always be guided by your vet because the diagnosis, follow-up schedule, and need for skin testing can vary from dog to dog.

Bravecto is dosed by body weight, so your dog should receive the exact product size prescribed by your vet. The original Bravecto chew is generally given every 12 weeks for flea control and most labeled tick species. In areas with heavy lone star tick exposure, your vet may recommend a shorter interval based on the label and your local parasite risk.

The original 12-week chew is labeled for dogs and puppies 6 months of age and older and 4.4 pounds or greater. Bravecto 1-Month is labeled for puppies and dogs 8 weeks of age and older and 4.4 pounds or greater, which can make it a practical option for younger puppies who need flea and tick protection before they are old enough for the 12-week chew.

Bravecto 1-Month should be given with food for best absorption. If your dog spits out part of a dose, vomits soon after taking it, or you are not sure the full dose stayed down, contact your vet before redosing. Keeping doses on time matters, because gaps in prevention can allow fleas to restart in the home and ticks to reattach outdoors.

Most dogs tolerate Bravecto well, but side effects can happen. The most commonly reported issues are vomiting, diarrhea, decreased appetite, and lethargy. Some dogs also have gas, itching, or mild digestive upset after a dose. These signs are often short-lived, but your vet should know if they are severe, repeated, or do not improve.

Like other drugs in the isoxazoline class, Bravecto carries an FDA safety caution for possible neurologic adverse reactions, including muscle tremors, ataxia, and seizures. These reactions are considered uncommon, and the FDA still considers isoxazolines safe and effective for most dogs. Even so, the warning matters if your dog has a seizure history or another neurologic condition.

See your vet immediately if your dog develops tremors, stumbling, collapse, repeated vomiting, facial swelling, or seizure activity after taking Bravecto. If your dog has had a prior reaction to an isoxazoline product, tell your vet before using Bravecto or a similar medication.

Bravecto is commonly used alongside other routine veterinary medications, including many heartworm preventives, antibiotics, pain medications, and vaccines. There are no widely recognized day-to-day drug interactions that prevent its use in most healthy dogs.

The bigger safety discussion is usually not a classic drug interaction. Instead, it is whether an isoxazoline is the right choice for a dog with a history of seizures, tremors, ataxia, or other neurologic disease. If your dog takes anti-seizure medication, has had unexplained fainting episodes, or has reacted badly to flea and tick products before, your vet may recommend a different prevention strategy.

Also mention if your dog is intended for breeding, pregnant, or nursing. Label updates note post-approval adverse event reports in breeding females, so this is an important conversation before treatment starts.